Stevanato Group S.p.A (STVN) Research & Development (2020 - 2026)
Stevanato Group S.p.A's (STVN) quarterly Research & Development came in at $6.8 million in Q1 2026, up 10.21% year-on-year from $6.2 million in Q1 2025, and up 1.3% on a QoQ basis from $6.8 million in Q4 2025.
Stevanato Group S.p.A (STVN) Research & Development (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Research & Development data on file, last reported at $6.8 million in Q1 2026.
- On a quarterly basis, Research & Development rose 10.21% year-over-year to $6.8 million in Q1 2026; TTM through Mar 2026 was $29.4 million, a 1.81% increase from a year earlier, with the FY2025 full-year figure at $29.6 million, down 12.72% from the prior year.
- Research & Development for Q1 2026 stood at $6.8 million, up from $6.8 million in the prior quarter.
- Over the last five years, Research & Development for STVN reached as high as $11.7 million in Q1 2024 and fell as low as $6.0 million in Q4 2024.
- Historically, Research & Development has averaged $8.5 million across 5 years, with a median of $8.9 million in 2025.
- Across the five-year window, Research & Development increased 26.56% in 2024 and sank 46.88% in 2025, its largest moves.
- Year by year, Research & Development stood at $10.8 million in 2022, then gained by 0.48% to $10.9 million in 2023, then slumped by 44.93% to $6.0 million in 2024, then advanced by 12.82% to $6.8 million in 2025, then increased by 1.3% to $6.8 million in 2026.
- Per Business Quant data, the three most recent Research & Development figures were $6.8 million in Q1 2026, $6.8 million in Q4 2025, and $8.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -245.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 370.60 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 249.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 94.27 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 42.50 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 189.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 98.66 Mn |
| 10 | Stevanato Group S.p.A | 5.29 Bn | 5.15 Bn | 88.01 Mn | 6.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.84 Mn |
| Dec 31, 2025 | 6.75 Mn |
| Sep 30, 2025 | 8.94 Mn |
| Jun 30, 2025 | 6.84 Mn |
| Mar 31, 2025 | 6.21 Mn |
| Dec 31, 2024 | 5.98 Mn |
| Sep 30, 2024 | 7.25 Mn |
| Jun 30, 2024 | 9.41 Mn |
| Mar 31, 2024 | 11.68 Mn |
| Dec 31, 2023 | 10.87 Mn |
| Sep 30, 2023 | 9.46 Mn |
| Jun 30, 2023 | 9.11 Mn |
| Mar 31, 2023 | 9.23 Mn |
| Dec 31, 2022 | 10.81 Mn |
| Sep 30, 2022 | 7.68 Mn |
| Jun 30, 2022 | 9.07 Mn |
| Mar 31, 2022 | 8.64 Mn |
| Dec 31, 2021 | 10.87 Mn |
| Sep 30, 2021 | 8.73 Mn |
| Jun 30, 2021 | 8.31 Mn |